By Jocelyn Aspa
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week’s NASDAQ biotech stock list.
By Micha Boon
Beleave Inc. (“Beleave” or the “Company”) (CSE:BE) (OTCQX:BLEVF) is pleased to announce the appointment of its new Chief Executive Officer, Andrew Wnek as Dr. Roger Ferreira moves into the role of Chief Science Officer.
“I am excited to join Beleave as Chief Executive Officer. The organization has an outstanding management team
Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform. The integration creates a simplified workflow and fully automated, end-to-end data analysis solution that allows
Maricann Group Inc. (CSE:MARI) announced that it has partnered with Julian Marley and International Cannabrands Ltd., a wholly owned subsidiary of GEA Technologies Ltd. (CSE:JUJU.A), to cultivate and formulate JuJu Royal™ products.
Zogenix, Aradigm, Vermillion, Aralez Pharmaceuticals and Kura Oncology top the NASDAQ biotech stock list.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
Soleno Therapeutics presented new efficacy data from the pilot clinical trial of Diazoxide Choline Controlled-Release Tablet treating Prader-Willi syndrome at the International Meeting of Pediatric Endocrinology.
By Shelly Kumar
FinCanna Capital Corp., the royalty investment company for licensed medical cannabis, and Astar Minerals Ltd. (TSX VENTURE: TAR) reports that FinCanna’s flagship investment, Cultivation Technologies, Inc. (CTI), has begun operations in Coachella, California with one of the state’s first permitted solvent extraction facilities for medical cannabis.
CTI established the medical cannabis extraction lab
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Cancer Genetics acquired a business that will help them expand their oncology offerings and mark in this sector.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.